Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of EUR 103.76 billion. The enterprise value is 121.19 billion.
Market Cap | 103.76B |
Enterprise Value | 121.19B |
Important Dates
The next estimated earnings date is Wednesday, May 21, 2025.
Earnings Date | May 21, 2025 |
Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.53% |
Shares Change (QoQ) | -0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 25.61.
PE Ratio | 25.61 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.56, with an EV/FCF ratio of 23.31.
EV / Earnings | 29.91 |
EV / Sales | 3.95 |
EV / EBITDA | 13.56 |
EV / EBIT | 19.49 |
EV / FCF | 23.31 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.54.
Current Ratio | 1.90 |
Quick Ratio | 1.19 |
Debt / Equity | 0.54 |
Debt / EBITDA | 2.75 |
Debt / FCF | 4.87 |
Interest Coverage | 8.90 |
Financial Efficiency
Return on equity (ROE) is 8.44% and return on invested capital (ROIC) is 5.49%.
Return on Equity (ROE) | 8.44% |
Return on Assets (ROA) | 4.66% |
Return on Invested Capital (ROIC) | 5.49% |
Return on Capital Employed (ROCE) | 8.62% |
Revenue Per Employee | 332,374 |
Profits Per Employee | 42,649 |
Employee Count | 95,000 |
Asset Turnover | 0.37 |
Inventory Turnover | 2.02 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.32% in the last 52 weeks. The beta is 0.82, so Medtronic's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | -1.32% |
50-Day Moving Average | 85.89 |
200-Day Moving Average | 80.53 |
Relative Strength Index (RSI) | 29.26 |
Average Volume (20 Days) | 1,735 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, Medtronic had revenue of EUR 31.58 billion and earned 4.05 billion in profits. Earnings per share was 3.11.
Revenue | 31.58B |
Gross Profit | 20.71B |
Operating Income | 6.41B |
Pretax Income | 4.97B |
Net Income | 4.05B |
EBITDA | 8.95B |
EBIT | 6.41B |
Earnings Per Share (EPS) | 3.11 |
Balance Sheet
The company has 7.53 billion in cash and 25.31 billion in debt, giving a net cash position of -17.74 billion.
Cash & Cash Equivalents | 7.53B |
Total Debt | 25.31B |
Net Cash | -17.74B |
Net Cash Per Share | n/a |
Equity (Book Value) | 47.19B |
Book Value Per Share | 36.60 |
Working Capital | 10.15B |
Cash Flow
In the last 12 months, operating cash flow was 6.94 billion and capital expenditures -1.74 billion, giving a free cash flow of 5.20 billion.
Operating Cash Flow | 6.94B |
Capital Expenditures | -1.74B |
Free Cash Flow | 5.20B |
FCF Per Share | n/a |
Margins
Gross margin is 65.59%, with operating and profit margins of 20.29% and 12.83%.
Gross Margin | 65.59% |
Operating Margin | 20.29% |
Pretax Margin | 15.73% |
Profit Margin | 12.83% |
EBITDA Margin | 28.34% |
EBIT Margin | 20.29% |
FCF Margin | 16.47% |
Dividends & Yields
This stock pays an annual dividend of 2.60, which amounts to a dividend yield of 3.22%.
Dividend Per Share | 2.60 |
Dividend Yield | 3.22% |
Dividend Growth (YoY) | 2.34% |
Years of Dividend Growth | 1 |
Payout Ratio | 84.62% |
Buyback Yield | 2.53% |
Shareholder Yield | 5.74% |
Earnings Yield | 3.90% |
FCF Yield | 5.01% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Medtronic has an Altman Z-Score of 2.88. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.88 |
Piotroski F-Score | n/a |